Sutezolid
Sutezolid is an oxazolidinone antibiotic that is currently under investigation for its potential use in the treatment of tuberculosis. It is a second-generation oxazolidinone, following linezolid, and has shown promise in early clinical trials.
History[edit | edit source]
Sutezolid was initially developed by Pfizer but was later acquired by Sequella, a biotech company. The drug entered Phase 2 clinical trials in 2014.
Mechanism of Action[edit | edit source]
Sutezolid, like other oxazolidinones, works by inhibiting protein synthesis in bacteria, thereby stopping their growth. It does this by binding to the bacterial ribosome and preventing the formation of a functional 70S-initiation complex, which is an essential component of the protein synthesis process.
Clinical Trials[edit | edit source]
In early clinical trials, sutezolid has shown promise in the treatment of tuberculosis. It has been found to be well-tolerated and to have a good safety profile. Further trials are needed to confirm these findings and to compare the efficacy of sutezolid with that of other drugs used in the treatment of tuberculosis.
Potential Advantages[edit | edit source]
Sutezolid has several potential advantages over other drugs used in the treatment of tuberculosis. It has a novel mechanism of action, which means it may be effective against strains of tuberculosis that are resistant to other drugs. It also has a good safety profile and is well-tolerated, which could make it a good option for long-term treatment.
See Also[edit | edit source]
References[edit | edit source]
Sutezolid Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD